Protective effects of alisma orientale extract against hepatic steatosis via inhibition of endoplasmic reticulum stress

International Journal of Molecular Sciences

Volumn 16, Issue 11, 2015, Pages 26151-26165

  Jang, Min Kyung ^a   Han, Yu Ran ^a   Nam, Jeong Soo ^a   Han, Chang Woo ^a   Kim, Byung Joo ^a   Jeong, Han Sol ^a   Ha, Ki Tae ^a   Jung, Myeong Ho ^a  

^a Pusan National University   (South Korea)

Author keywords

Alisma orientale; ApoB secretion; Endoplasmic reticulum stress; Hepatic steatosis; Lipogenesis; Triglyceride accumulation; Very low density lipoprotein receptor

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; ALISMA ORIENTALE EXTRACT; APOLIPOPROTEIN B; DIMETHYL SULFOXIDE; GLUCOSE REGULATED PROTEIN 78; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; INTERLEUKIN 6; MEMBRANE PROTEIN; MESSENGER RNA; METHANOL; MONOCYTE CHEMOTACTIC PROTEIN 1; PLANT EXTRACT; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN RECEPTOR; X BOX BINDING PROTEIN 1; HEAT SHOCK PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MOLECULAR CHAPERONE GRP78; PROTECTIVE AGENT; TUNICAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; FATTY LIVER; GENE EXPRESSION; HEPATOCELLULAR CARCINOMA CELL LINE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INFLAMMATION; LUCIFERASE ASSAY; MOUSE; MTT ASSAY; NONHUMAN; OBESITY; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; RNA SPLICING; WESTERN BLOTTING; ALISMA; ANIMAL; CELL SURVIVAL; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEP-G2 CELL LINE; LIPID DIET; METABOLISM; MOUSE MUTANT; PATHOLOGY; SECRETION (PROCESS);

ALISMA; ANIMALS; APOLIPOPROTEINS B; CELL SURVIVAL; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; ENDOPLASMIC RETICULUM STRESS; FATTY LIVER; GENE EXPRESSION REGULATION; HEAT-SHOCK PROTEINS; HEP G2 CELLS; HUMANS; INFLAMMATION; MICE; MICE, OBESE; PLANT EXTRACTS; PROTECTIVE AGENTS; RECEPTORS, LDL; TRIGLYCERIDES; TUNICAMYCIN;

EID: 84946571432     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms161125944     Document Type: Article

References (28)

1. Farrell, G.C.; Larter, C.Z. Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology 2006, 43, S99–S112. [CrossRef] [PubMed]
2. Postic, C.; Girard, J. The role of the lipogenic pathway in the development of hepatic steatosis. Diabetes Metab. 2008, 34, 643–648. [CrossRef]
3. Dai, Y.; Hang, B.; Huang, Z.; Li, P. Anti-inflammatory activities and effect of rhizoma Alismatis on immune system. Zhongguo Zhong Yao Za Zhi 1991, 16, 622–625. [PubMed]
4. Lee, J.H.; Kwon, O.S.; Jin, H.G.; Woo, E.R.; Kim, Y.S.; Kim, H.P. The rhizomes of Alisma orientale and alisol derivatives inhibit allergic response and experimental atopic dermatitis. Biol. Pharma. Bull. 2012, 35, 1581–1587. [CrossRef]
5. Han, C.W.; Kang, E.S.; Ham, S.A.; Woo, H.J.; Lee, J.H.; Seo, H.G. Antioxidative effects of Alisma orientale extract in palmitate-induced cellular injury. Pharm. Biol. 2012, 50, 1281–1288. [CrossRef] [PubMed]
6. Hong, X.; Tang, H.; Wu, L.; Li, L. Protective effects of the Alisma orientalis extract on the experimental nonalcoholic fatty liver disease. J. Pharm. Pharmacol. 2006, 58, 1391–1398 . [CrossRef] [PubMed]
7. Tian, T.; Chen, H.; Zhao, Y. Traditional uses, phytochemistry, pharmacology, toxicology and quality control of Alisma orientale (Sam.) Juzep: A review. J. Ethnopharmcol. 2014, 158, 373–387. [CrossRef] [PubMed]
8. Ron, D.; Walter, P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 2007, 8, 519–529. [CrossRef] [PubMed]
9. Fu, S.; Watkins, S.M.; Hotamisligil, G.S. The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling. Cell Metab. 2012, 15, 623–634. [CrossRef] [PubMed]
10. Walter, P.; Ron, D. The unfolded protein response: From stress pathway to homeostatic regulation. Science 2011, 334, 1081–1086. [CrossRef] [PubMed]
11. Fonseca, S.G.; Burcin, M.; Gromada, J.; Urano, F. Endoplasmic reticulum stress in -cells and development of diabetes. Curr. Opin. Pharmacol. 2009, 9, 763–770. [CrossRef] [PubMed]
12. Malhi, H.; Kaufman, R.J. Endoplasmic reticulum stress in liver disease. J. Hepatol. 2011, 54, 795–809. [CrossRef] [PubMed]
13. Dandekar, A.; Mendez, R.; Zhang, K. Cross talk between ER stress, oxidative stress, and inflammation in health and disease. Methods Mol. Biol. 2015, 1292, 205–214. [PubMed]
14. Lee, A.H.; Scapa, E.F.; Cohen, D.E.; Glimcher, L.H. Regulation of hepatic lipogenesis by the transcription factor XBP1. Science 2008, 320, 1492–1496. [CrossRef] [PubMed]
15. Bobrovnikova-Marjon, E.; Hatzivassiliou, G.; Grigoriadou, C.; Romero, M.; Cavener, D.R.; Thompson, C.B.; Diehl, J.A. PERK-dependent regulation of lipogenesis during mouse mammary gland development and adipocyte differentiation. Proc. Natl. Acad. Sci. USA 2008, 105, 16314–16319. [CrossRef] [PubMed]
16. Lee, J.S.; Zheng, Z.; Mendez, R.; Ha, S.W.; Xie, Y.; Zhang, K. Pharmacologic ER stress induces non-alcoholic steatohepatitis in an animal model. Toxicol. Lett. 2012, 211, 29–38. [CrossRef] [PubMed]
17. Jo, H.; Choe, S.S.; Shin, K.C. Endoplasmic reticulum stress induces hepatic steatosis via increased expression of the hepatic very low-density lipoprotein receptor. Hepatology 2014, 57, 1366–1377. [CrossRef] [PubMed]
18. Ota, T.; Gayet, C.; Ginsberg, H.N. Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents. J. Clin. Investig. 2008, 118, 316–332. [CrossRef] [PubMed]
19. Guo, B.; Li, Z. Endoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseases. Front. Genet. 2014, 5, 242–252. [CrossRef] [PubMed]
20. Peng, G.P.; Zhu, Y.L. Progress in the study on chemical constituents of Alisma orientalis. Nat. Prod. Res. 2006, 18, 348–351.
21. Vilatoba, M.; Eckstein, C.; Bilbao, G. Sodium 4-phenylbutyrate protects against liver ischemia reperfusion injury by inhibition of endoplasmic reticulum-stress mediated apoptosis. Surgery 2005, 138, 342–351. [CrossRef] [PubMed]
22. Ozcan, U.; Yilmaz, E.; Ozcan, L. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006, 313, 1137–1140. [CrossRef] [PubMed]
23. Xie, Q.; Khaoustov, V.I.; Chung, C.C. Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. Hepatology 2002, 36, 592–601. [CrossRef] [PubMed]
24. Tamaki, N.; Hatano, E.; Taura, K.; Tada, M.; Kodama, Y.; Nitta, T.; Iwaisako, K.; Seo, S.; Nakajima, A.; Ikai, I.; et al. CHOP deficiency attenuates cholestasisinduced liver fibrosis by reduction of hepatocyte injury. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294, G498–G505. [CrossRef] [PubMed]
25. Jiang, Z.Y.; Zhang, X.M.; Zhang, F.X.; Liu, N.; Zhao, F.; Zhou, J.; Chen, J.J. A new triterpene and anti-hepatitis B virus active compounds from Alisma orientalis. Planta Med. 2006, 72, 951–954. [CrossRef] [PubMed]
26. Jin, H.G.; Jin, Q.; Kim, A.; Choi, H.; Lee, J.H.; Kim, Y.S.; Lee, D.G.; Woo, E.R. A new triterpenoid from Alisma orientale and their antibacterial effect. Arch. Pharmacal. Res. 2012, 35, 1919–1926. [CrossRef] [PubMed]
27. Kim, N.Y.; Kang, T.H.; Pae, H.O.; Choi, B.M.; Chung, H.T.; Myung, S.W.; Song, Y.S.; Sohn, D.H.; Kim, Y.C. In vitro inducible nitric oxide synthesis inhibitors from Alismatis Rhizoma. Biol. Pharm. Bull. 1999, 22, 1147–1149. [CrossRef] [PubMed]
28. Matsuda, H.; Kobayashi, G.; Yamahara, J.; Fujimura, H.; Kurahashi, K.; Fujiwara, M. Effects of alismol isolated from Alismatis Rhizoma on calcium-induced contraction in the rabbit thoracic aorta. Life Sci. 1987, 41, 1845–1852. [CrossRef]